Oxaprozin |
Daypro |
Article: Oxaprozin
![]() | |
| Oxaprozin | |
| Systematic (IUPAC) name | |
| 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid | |
| Identifiers | |
| CAS number | 21256-18-8 |
| ATC code | M01AE12 |
| PubChem | 4614 |
| DrugBank | APRD00030 |
| Chemical data | |
| Formula | C18H15NO3 |
| Mol. weight | 293.317 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 99% |
| Metabolism | ? |
| Half life | 54.9 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Oxaprozin (brand name: Daypro®) is a nonnarcotic, nonsteroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative.
Categories: Medical treatment stubs | Non-steroidal anti-inflammatory drugs

Not Signed In - 

